Patrick Burnett, See Remarks at Arcutis Biotherapeutics, Inc. (ARQT), sold 32,046 shares at $10.14 ($325K) on 2024-11-22, disclosed to the SEC on 2024-11-26.
Open-market sale of $325k ARQT by See Remarks. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.14 | 16,023 | $162K | 50.0% |
| 2 | $10.14 | 16,023 | $162K | 50.0% |
| Total | $10.14 avg | 32,046 | $325K | 100% |
| Filing → |
| ARQT | SELL | 2026-08-05 | $25K | — | Filing → |
| ARQT | SELL | 2026-05-13 | $5K | — | Filing → |
| ARQT | SELL | 2026-05-06 | $16K | — | Filing → |